Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05425004
Title Cabozantinib for Patients With Recurrent or Progressive Meningioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baptist Health South Florida
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Miami Cancer Institute at Baptist Health, Inc. RECRUITING Miami Florida 33176 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field